HARMONY BIOSCIENCES HOLDINGS, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $868.5M | $714.7M | $582.0M | $437.9M | $305.4M | $159.7M | $6.0M |
| Cost of Revenue | $198.3M | $156.8M | $121.2M | $83.5M | $55.5M | $27.7M | $1.6M |
| Gross Profit | $670.1M | $557.9M | $460.8M | $354.4M | $249.9M | $132.0M | $4.4M |
| Gross Margin | 77.2% | 78.1% | 79.2% | 80.9% | 81.8% | 82.6% | 73.7% |
| Operating Expenses | |||||||
| Research & Development | $189.6M | $145.8M | $76.1M | $70.9M | $30.4M | $19.4M | $69.6M |
| SG&A Expense | $152.5M | $110.4M | $95.3M | $84.0M | $63.9M | $39.7M | $36.4M |
| Operating Income | $208.5M | $190.8M | $192.0M | $120.2M | $87.5M | $17.0M | $-145.9M |
| Operating Margin | 24.0% | 26.7% | 33.0% | 27.4% | 28.7% | 10.6% | -2,433.8% |
| Interest Expense | $14.6M | $17.5M | $23.8M | $18.8M | $24.2M | $28.6M | $7.4M |
| Pretax Income | $215.1M | $191.8M | $173.4M | $104.7M | $37.4M | $-36.9M | $-152.0M |
| Income Tax Expense | $56.4M | $46.3M | $44.5M | $-76.8M | $2.8M | — | — |
| Net Income | $158.7M | $145.5M | $128.9M | $181.5M | $34.6M | $-36.9M | $-152.0M |
| Net Margin | 18.3% | 20.4% | 22.1% | 41.4% | 11.3% | -23.1% | -2,535.1% |
| EPS (Basic) | $2.76 | $2.56 | $2.17 | $3.07 | $0.60 | $-1.24 | $-4.01 |
| EPS (Diluted) | $2.71 | $2.51 | $2.13 | $2.97 | $0.58 | $-1.24 | $-4.01 |
| Shares Outstanding (Basic) | 57.5M | 56.9M | 59.5M | 59.2M | 57.5M | 51.5M | 46.7M |
| Shares Outstanding (Diluted) | 58.5M | 57.9M | 60.4M | 61.1M | 59.2M | 51.5M | 46.7M |
| Dividends Per Share | — | — | — | — | — | — | — |